← All organizations
Highest phase reached
Phase 4
First clinical trial
Apr 1, 1965Last known activity
May 15, 2026
Timeline
1940s
- Jun 16, 1948
National Heart, Lung, and Blood Institute (NHLBI)— Founded
Drugs by trial phase (651 distinct, 1094 trials)
Phase 4 (143 own, 0 via acquisition)
Phase 3 (184 own, 0 via acquisition)
Phase 2 (195 own, 0 via acquisition)
Phase 1 (84 own, 0 via acquisition)
- mannitol
- sodium nitrate
- 18f-2-fluoro-2-deoxy-d-glucose fluorodeoxyglucose
- 18f 4-l-fluoroglutamine
- acp-501
- cmv-specific t-cells
- Hydroxymethylfurfural
- allogeneic natural killer cells
- angiotensin ii
- anx-042
- lorcaserin
- alprazolam
- c46/ccr5/p140k lentiviral vector-transduced autologous hspcs
- norepinephrine
- clofarabine
- +69 more
Other trials (45 own, 0 via acquisition)
Indications
Studied for
- Abnormalities, Drug-Induced
- Acidosis
- Acidosis, Lactic
- Acquired Immunodeficiency Syndrome
- Acute Chest Syndrome
- Acute Coronary Syndrome
- Acute Lung Injury
- Acute Pain
- Adenoviridae Infections
- Aggression
- AIDS-Related Complex
- Albuminuria
- alpha 1-Antitrypsin Deficiency
- Alzheimer Disease
- Anemia
- Anemia, Aplastic
- Anemia, Diamond-Blackfan
- Anemia, Hemolytic
- Anemia, Hemolytic, Congenital
- Anemia, Iron-Deficiency
- Anemia, Neonatal
- Anemia, Refractory
- Anemia, Refractory, with Excess of Blasts
- Anemia, Sickle Cell
- Aneurysm
- Angina Pectoris
- Angina, Unstable
- Angioedema
- Apnea
- Arachnodactyly
- Arrhythmia, Sinus
- Arterial Occlusive Diseases
- Arteriosclerosis
- Arthritis
- Arthritis, Rheumatoid
- Ascites
- Aspergillosis
- Aspergillosis, Allergic Bronchopulmonary
- Asthma
- Atherosclerosis
- Atrial Fibrillation
- Atrophy
- Autonomic Nervous System Diseases
- Beriberi
- beta-Thalassemia
- Birth Weight
- Blast Crisis
- Blood Coagulation Disorders
- Bone Diseases
- Bone Marrow Diseases
- Brain Injuries
- Brain Injuries, Traumatic
- Breast Neoplasms
- Bronchiolitis
- Bronchiolitis Obliterans
- Bronchitis
- Bronchitis, Chronic
- Bronchopulmonary Dysplasia
- Burkitt Lymphoma
- Calcinosis
- Carcinoma
- Carcinoma, Medullary
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Ovarian Epithelial
- Carcinoma, Renal Cell
- Cardiomegaly
- Cardiomyopathies
- Cardiomyopathy, Dilated
- Cardiomyopathy, Hypertrophic
- Cardio-Renal Syndrome
- Cardiovascular Diseases
- Carotid Artery Diseases
- Carotid Stenosis
- Cataract
- Cerebrovascular Disorders
- Chest Pain
- Chickenpox
- Chlamydia Infections
- Cognitive Dysfunction
- Colonic Neoplasms
- Colorectal Neoplasms
- Communicable Diseases
- Congenital Abnormalities
- Connective Tissue Diseases
- Constriction, Pathologic
- Coronary Aneurysm
- Coronary Artery Disease
- Coronary Disease
- Coronavirus Infections
- Cough
- Critical Illness
- Cystic Fibrosis
- Cytomegalovirus Infections
- Death
- Death, Sudden
- Death, Sudden, Cardiac
- Deficiency Diseases
- Delirium
- Depression
- Depressive Disorder
Recent trials (50)
- NCT07225543CollaboratorPhase 2May 15, 2026
- NCT07232069CollaboratorPhase 3Apr 1, 2026
- NCT07303816CollaboratorPhase 4Apr 1, 2026
- NCT07228104CollaboratorPhase 3Jan 1, 2026
- NCT07085039CollaboratorPhase 2Dec 15, 2025
- NCT06923072OfficialPhase 2Dec 2, 2025
- NCT06923072Lead sponsorPhase 2Dec 2, 2025
- NCT06948097Lead sponsorPhase 1Dec 2, 2025
- NCT06948097OfficialPhase 1Dec 2, 2025
- NCT07238400CollaboratorPhase 2Dec 1, 2025
- NCT06957821CollaboratorEarly Phase 1Oct 30, 2025
- NCT06961630CollaboratorEarly Phase 1Oct 7, 2025
- NCT06990711CollaboratorPhase 1Sep 1, 2025
- NCT07103616CollaboratorPhase 4Sep 1, 2025
- NCT06949644CollaboratorN/AAug 1, 2025
Details
- Founded
- Bethesda, MD, US Jun 16, 1948
- Last known activity
- May 15, 2026